# Safety and Immune Response to an Investigational Dengue Type 2 Vaccine

> **NCT01073306** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 18 (actual)

## Conditions studied

- Dengue Virus

## Interventions

- **BIOLOGICAL:** Investigational Vaccine for Dengue Virus Subtype 2
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01073306
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01073306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01073306, "Safety and Immune Response to an Investigational Dengue Type 2 Vaccine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01073306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*